Isotretinoïne en het skelet

Isotretinoïne en het skelet
6. Mc GUIRE J., MILSTONE L., LAWSON J. Isotretinoin administration alters juvenile and adult bone. In “Retinoids: New Trends in
Research and Therapy”, Retinoid Symp. Geneva 1984, Karger Basel Ed., 1985, 419-39.
7. LAWSON J.P., Mc GUIRE J. The spectrum of skeletal changes associated with long-term administration of 13-cis-retinoic acid. Skeletal
Radiol., 1987; 16: 91-7.
8. PITTSLEY R.A., YODER F.W. Retinoid hyperostosis skeletal toxicity associated with long-term administration of 13-cis-retinoic acid for
refractory ichthyosis. N. Engl. J. Med. 1983; 308: 1012-4.
9. PENNES D.R., ELLIS C.N., MADISON K.C., VOORHEES J.J., MARTEL W. Early skeletal hyperostoses secondary to 13-cis-retinoic
acid. Am. J. Roentgenol. 1984; 142: 979-83.
10. GERBER L.H., HELFGOTT R.K., GROSS E.G., HICKS J.E., ELLENBERG S.S., PECK G.L. Vertebral abnormalities associated with
synthetic retinoid use. J. Am. Acad. Dermatol. 1984; 5: 817-23.
11. DENMAN S., CUNNINGHAM W., KILCOYNE R.F., FRANZ T., COPE R., HANIFIN J. Isotretinoin therapy of cystic acne is associated
with skeletal radiographic changes. Clin. Research. 1985; 33: A 153 (Abstract).
12. KILCOYNE R.F., COPE R., CUNNINGHAM W., NARDELLA F.A., DENMAN S., FRANZ T.J., HANIFIN J. Minimal spinal
hyperostosis with low-dose isotretinoin therapy. lnvest. Radiol. 1986; 21: 41-4.
13. PENNES D.R., MARTEL W., ELLIS C.N., VOORHEES J.J. Evolution of skeletal hyperostoses caused by
13-cis-retinoic acid therapy. Am. J. Roentgenol. 1988; 151: 967-73.
14. PENNES D.R., MARTEL W., ELLIS C.N. Retinoid-induced ossification of the posterior longitudinal ligament. Skeletal Radiol. 1985;
14: 191-3.
15. TANGREA J.A., KILCOYNE R.F., TAYLOR P.R., HELSEL W.E., ADRIANZA M.E., HARTMAN A.M., EDWARDS B.K., PECK
G.L. Skeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoin. Arch. Dermatol. 1992; 128: 921-5.
16. TANGREA J.A., TAYLOR P.R., HARTMAN A.M., EDWARDS B.K., KILCOYNE R.F., HELSEL W.E., ADRIANZA M.E., PECK
G.L. Isotretinoin and the axial skeleton. Lancet 1992; 340: 495-6.
17. ELLIS C.N., PENNES D.R., HERMANN R.C., BLAUVELT A., MARTEL W., VOORHEES J.J. Long-term radiographic follow-up
after isotretinoin therapy. J. Am. Acad. Dermatol. 1988; 18: 1252-61.
18. CAREY B.M., PARKIN G.J.S., CUNLIFFE W.J., PRITLOVE J. Skeletal toxicity with isotretinoin therapy: a clinico-radiological evaluation.
Br. J. Dermatol. 1988; 119: 609-14.
19. DIGIOVANNA J.J., HELFGOTT R., GERBER L. H., PECK G.L. Extraspinal tendon and ligament calcification after long-term isotretinoin
therapy. J. Invest. Dermatol.1987; 88: 485 (Abstract).
20. NOVICK N.L., LAWSON W., SCHWARTZ I.S. Bilateral nasal bone osteophytosis associated with short-term oral isotretinoin therapy for
cystic acne vulgaris. Am. J. Med. 1984; 77: 736-9.
21. SCUDERI A.J., DATZ F.L., VALDIVIA S., MORTON K.A. Enthesopathy of the patellar tendon insertion associated with isotretinoin
therapy. J. Nucl. Med. 1993; 34: 455-7.
22. GOULDEN V., LAYTON A.M., CUNLIFFE W.J. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br. J. Dermatol.
1994; 131: 360-3.
23. BOACHIE-ADJEI O., BULLOUGH P.G. Incidence of ankylosing hyperostosis of the spine (Forestier's disease) at autopsy. Spine 1987; 12:
739-43.
24. TOROK L., BUDAI S., KASA M., KADAR L. Bone X-ray examinations in patients treated with isotretinoin: a prospective study. Br. J.
Dermatol. 1988; 118: 134-5.
25. GROSSHANS E., BOURGAULT I., JOURDAN J. et al. Traitements de l’acné par voie générale. Indications et problèmes posés. Ann.
Dermatol. Venereol. 1995; 122: 30-6
26. LING T.C., PARKIN G., ISLAM J., SEUKERAN D.C., CUNLIFFE W.J. What is the cumulative effect of long-term, low-dose isotretinoin
on the development of DISH ? Br. J. Dermatol. 2001; 144: 630-632.
27. MELHUS H., MICHAELSSON K., KINDMARK A., BERGSTROM R., HOLMBERG L., MALLMIN H., WOLK A., LJUNG-
HALL S. Excessive dietary intake of Vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann.
Intern. Med. 1998; 129: 770-8.
28. LEACHMAN S.A., INSOGNA K. L., KATZ L., ELLISON A., MILSTONE L.M. Bone densities in patients receiving isotretinoin for
cystic acne. Arch. Dermatol. 1999; 135: 961-5.
29. DIGIOVANNA J.J., SOLLITTO R.B., ABANGAN D.L., STEINBERG S.M., REYNOLDS J.C. Osteoporosis is a toxic effect of longterm
etretinate therapy. Arch. Dermatol. 1995; 131: 1263-7.
30. KOCIJANCIC M. 13-cis retinoic acid and bone density. Int. J. Dermatol. 1995; 34: 733-4.
31. MILSTONE L.M., McGUIRE J., ABLOW R.C. Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J. Am. Acad.
Dermatol. 1982; 7: 663-6.
32. MARINI J.C., HILL S., ZASLOFF M.A. Dense metaphyseal bands and growth arrest associated with isotretinoin therapy. Am. J. Dis.
Child. 1988; 142: 316-8.
33. NISHIMURA G., MUGISHIMA H., HIRAO J., YAMATO M. Generalized metaphyseal modification with cone-shaped epiphyses following
long-term administration of 13-cis-retinoic acid. Eur. J. Pediatr. 1997; 156: 432-5.
34. BUTENANDT O. Vorzeitiger epiphysenfugenschluß unter isotretinointherapie. Monastsschr. Kinderheilkd., 1995; 143: 1252-4.
– 6 –